Literature DB >> 14643948

Towards genetic prediction of radiation responses: ESTRO's GENEPI project.

Michael Baumann, Tobias Hölscher, Adrian C Begg.   

Abstract

Mesh：

Year:  2003        PMID： 14643948     DOI： 10.1016/j.radonc.2003.08.006

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN： 0167-8140            Impact factor:   6.280


× No keyword cloud information.
  16 in total

1.  Molecular biology: the key to personalised treatment in radiation oncology?

Authors:  D G Hirst; T Robson
Journal:  Br J Radiol       Date:  2010-09       Impact factor: 3.039

2.  Randomized controlled trials in health technology assessment: overkill or overdue?

Authors:  Søren M Bentzen
Journal:  Radiother Oncol       Date:  2008-01-30       Impact factor: 6.280

3.  Radiation induced apoptosis and initial DNA damage are inversely related in locally advanced breast cancer patients.

Authors:  Beatriz Pinar; Luis Alberto Henríquez-Hernández; Pedro C Lara; Elisa Bordon; Carlos Rodriguez-Gallego; Marta Lloret; Maria Isabel Nuñez; Mariano Ruiz De Almodovar
Journal:  Radiat Oncol       Date:  2010-09-24       Impact factor: 3.481

4.  Early and late skin reactions to radiotherapy for breast cancer and their correlation with radiation-induced DNA damage in lymphocytes.

Authors:  Escarlata López; Rosario Guerrero; Maria Isabel Núñez; Rosario del Moral; Mercedes Villalobos; Joaquina Martínez-Galán; Maria Teresa Valenzuela; José Antonio Muñoz-Gámez; Francisco Javier Oliver; David Martín-Oliva; José Mariano Ruiz de Almodóvar
Journal:  Breast Cancer Res       Date:  2005-07-01       Impact factor: 6.466

Review 5.  Creating a data exchange strategy for radiotherapy research: towards federated databases and anonymised public datasets.

Authors:  Tomas Skripcak; Claus Belka; Walter Bosch; Carsten Brink; Thomas Brunner; Volker Budach; Daniel Büttner; Jürgen Debus; Andre Dekker; Cai Grau; Sarah Gulliford; Coen Hurkmans; Uwe Just; Mechthild Krause; Philippe Lambin; Johannes A Langendijk; Rolf Lewensohn; Armin Lühr; Philippe Maingon; Michele Masucci; Maximilian Niyazi; Philip Poortmans; Monique Simon; Heinz Schmidberger; Emiliano Spezi; Martin Stuschke; Vincenzo Valentini; Marcel Verheij; Gillian Whitfield; Björn Zackrisson; Daniel Zips; Michael Baumann
Journal:  Radiother Oncol       Date:  2014-10-28       Impact factor: 6.280

6.  Application of radiomics signature captured from pretreatment thoracic CT to predict brain metastases in stage III/IV ALK-positive non-small cell lung cancer patients.

Authors:  Xinyan Xu; Lyu Huang; Jiayan Chen; Junmiao Wen; Di Liu; Jianzhao Cao; Jiazhou Wang; Min Fan
Journal:  J Thorac Dis       Date:  2019-11       Impact factor: 2.895

Review 7.  Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype.

Authors:  Gillian C Barnett; Catherine M L West; Alison M Dunning; Rebecca M Elliott; Charlotte E Coles; Paul D P Pharoah; Neil G Burnet
Journal:  Nat Rev Cancer       Date:  2009-01-16       Impact factor: 60.716

8.  Epigenetic Modulation of Radiation-Induced Diacylglycerol Kinase Alpha Expression Prevents Pro-Fibrotic Fibroblast Response.

Authors:  Chun-Shan Liu; Reka Toth; Ali Bakr; Ashish Goyal; Md Saiful Islam; Kersten Breuer; Anand Mayakonda; Yu-Yu Lin; Peter Stepper; Tomasz P Jurkowski; Marlon R Veldwijk; Elena Sperk; Carsten Herskind; Pavlo Lutsik; Dieter Weichenhan; Christoph Plass; Peter Schmezer; Odilia Popanda
Journal:  Cancers (Basel)       Date:  2021-05-18       Impact factor: 6.639

9.  Clinical risk factors for late intestinal toxicity after radiotherapy: a systematic review protocol.

Authors:  Qiyuan Qin; Qingshan Huang; Qinghua Zhong; Xinjuan Fan; Dianke Chen; Lei Wang
Journal:  Syst Rev       Date:  2013-06-07

10.  Analysis of gene expression using gene sets discriminates cancer patients with and without late radiation toxicity.

Authors:  J Peter Svensson; Lukas J A Stalpers; Rebecca E E Esveldt-van Lange; Nicolaas A P Franken; Jaap Haveman; Binie Klein; Ingela Turesson; Harry Vrieling; Micheline Giphart-Gassler
Journal:  PLoS Med       Date:  2006-10       Impact factor: 11.069
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.